Related Experiment Video
Updated: Apr 6, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Effect of Rab23 on the proliferation and apoptosis in breast cancer
Yali Liu1, Chao Zeng1, Nandi Bao2
1Department of Physiology, State Key Discipline of Cell Biology, The Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China.
Abstract:
Rab23, as a negative regulatory molecule of the Hedgehog (Hh) signaling pathway, may be a new target for treating carcinoma. In the present study, we aimed to determine whether Rab23 is expressed in breast cancer cells and whether Rab23 affects the viability and proliferation of breast cancer cells. We evaluated Rab23 expression in several breast cancer cell lines including MDA-MB-231, Bcap37 and MCF-7 by reverse transcription-PCR (RT-PCR), western blotting and immunofluorescence in vitro. We assessed cell growth and proliferation by 3-(4,5-dimethylthiazol‑2-y1)‑3,5-diphenyltetrazolium bromide (MTT), colony formation and bromodeoxyuridine (BrdU) incorporation assays. The distribution of the cell cycle and the rate of apoptosis were assessed using flow cytometry (FCM). In addition, we determined the mechanisms by which Rab23 regulates the Hh pathway by detecting the level of Gli molecules by RT-PCR. We found that Rab23 mRNA and protein levels were expressed in breast cancer cells, and the expression of Rab23 in MDA-MB-231 cells was higher than that in the MCF-7 cells. Rab23 protein was primarily expressed and localized in the cytoplasm surrounding the nucleus. The MTT assay showed that the absorbance value at A(490 nm) of the Rab23‑transfected group was reduced in comparison with the control group. The number of colonies formed in the breast cancer cells was significantly reduced and BrdU labeling was weakened in the group transfected with Rab23. The results of FCM showed that overexpression of Rab23 protein caused cell cycle arrest in the G1 phase and a decrease in the S phase population as well as induction of apoptosis. Furthermore, Rab23 decreased Gli1 and Gli2 mRNA levels when compared with the control group. Our results indicate that Rab23 is expressed in breast cancer cells, and ectopic expression of Rab23 inhibits the growth and proliferation as well as induces cell apoptosis in breast cancer cells. These effects may be due to the inhibition by Rab23 of Gli1 and Gli2 mRNA expression. These results suggest that Rab23 is a potential target for the treatment of breast cancer.
Insights
Rab23 is expressed in breast cancer cells and inhibits their growth and proliferation. Overexpression of Rab23 induces apoptosis, suggesting it
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The Hedgehog (Hh) signaling pathway plays a crucial role in various cancers.
- Rab23 acts as a negative regulator of the Hh pathway.
- Dysregulation of Hh signaling is implicated in carcinoma development.
Purpose of the Study:
- To investigate Rab23 expression in breast cancer cell lines.
- To determine the effect of Rab23 on breast cancer cell viability and proliferation.
- To elucidate the mechanism by which Rab23 regulates the Hh pathway in breast cancer.
Main Methods:
- Rab23 expression analyzed by RT-PCR, western blotting, and immunofluorescence.
- Cell viability and proliferation assessed using MTT, colony formation, and BrdU assays.
- Cell cycle distribution and apoptosis evaluated by flow cytometry (FCM).
- Hedgehog pathway regulation studied by detecting Gli molecule levels via RT-PCR.
Main Results:
- Rab23 mRNA and protein are expressed in breast cancer cells (MDA-MB-231, Bcap37, MCF-7).
- Rab23 overexpression reduced cell viability, colony formation, and BrdU incorporation.
- Rab23 induced G1 cell cycle arrest, decreased S phase population, and promoted apoptosis.
- Rab23 decreased Gli1 and Gli2 mRNA levels, indicating Hh pathway inhibition.
Conclusions:
- Rab23 is expressed in breast cancer cells and inhibits their growth and proliferation.
- Rab23 induces apoptosis in breast cancer cells, potentially via Gli1 and Gli2 downregulation.
- Rab23 represents a potential therapeutic target for breast cancer treatment.
Related Concept Videos
Negative Regulator Molecules
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
The Intrinsic Apoptotic Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

